Clinical Trials for CARsgen Therapeutics

Explore 20 clinical trials worldwide

Showing 1-20 of 20 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: CARsgen Therapeutics

Clinical Trials (20)

NCT06730256
A Study of CT0596 in Relapsed/Refractory Multiple Myeloma and Relapsed/ Refractory Plasma Cell Leukemia
EARLY_PHASE1Recruiting
24 participants
Started: Jul 23, 2025 · Completed: Dec 31, 2027
2 conditions2 sponsors1 location
NCT07033299
The Safety, Efficacy, and Cellular Metabolic Kinetics of CT1192 in Treating Patients With Anti Neutrophil Cytoplasmic Antibody Associated Vasculitis
PHASE1Not yet recruiting
12 participants
Started: Jul 1, 2025 · Completed: Mar 31, 2027
1 condition2 sponsors1 location
NCT06988059
A Study of CT0596 in Plasma Cell Leukemia
EARLY_PHASE1Recruiting
27 participants
Started: Jun 25, 2025 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT07031713
Safety, Efficacy and Cellular Metabolic Dynamics of ct1192 in Patients With Moderate to Severe Refractory SLE
PHASE1Not yet recruiting
12 participants
Started: Jun 16, 2025 · Completed: Mar 31, 2027
1 condition2 sponsors1 location
NCT06825845
Long Term Follow-up Observational Study in Patients Treated with Gene-Modified T-Cell Therapy
N/ANot yet recruiting
1,500 participants
Started: Mar 31, 2025 · Completed: Jun 30, 2040
1 condition1 sponsor0 locations
NCT06822881
CT1190B in the Treatment of Patients With Moderate to Severe Refractory Systemic Lupus Erythematosus (SLE) or Refractory/Progressive Systemic Sclerosis (SSc)
PHASE1Recruiting
27 participants
Started: Feb 20, 2025 · Completed: Dec 31, 2026
2 conditions2 sponsors1 location
NCT06718270
a Study of CT0596 in Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Plasma Cell Leukemia
EARLY_PHASE1Recruiting
24 participants
Started: Dec 11, 2024 · Completed: Dec 31, 2027
2 conditions2 sponsors1 location
NCT06659770
A Real-World Observational Study: Zevorcabtagene Autoleucel Injection in Patients with Relapsed/Refractory Multiple Myeloma
N/ANot yet recruiting
200 participants
Started: Oct 31, 2024 · Completed: Dec 31, 2027
1 condition1 sponsor0 locations
NCT06407947
Study of CT071 Injection in High Risk Newly Diagnosed Multiple Myeloma
EARLY_PHASE1Recruiting
10 participants
Started: Jun 6, 2024 · Completed: Jun 3, 2027
1 condition2 sponsors1 location
NCT06333509
Anti-GPRC5D CAR-T Cells (CT071) in Participants With RRMM or RRpPCL
PHASE1/PHASE2Not yet recruiting
166 participants
Started: Apr 15, 2024 · Completed: Dec 31, 2027
2 conditions1 sponsor0 locations
NCT06560827
CT011 Autologous CAR-T Cells in Patients With Hepatocellular Carcinoma at Risk of Recurrence After Surgical Resection
PHASE1Recruiting
30 participants
Started: Oct 8, 2023 · Completed: Jun 30, 2027
1 condition2 sponsors15 locations
NCT05911217
A Study to Evaluate the Efficacy and Safety of CT041 After Adjuvant Chemotherapy for Pancreatic Cancer
PHASE1Recruiting
20 participants
Started: Jul 11, 2023 · Completed: Dec 31, 2026
1 condition2 sponsors8 locations
NCT05838131
Study of CT071 Injection in RRMM or PPCL
EARLY_PHASE1Active, not recruiting
20 participants
Started: Apr 28, 2023 · Completed: Jul 31, 2025
2 conditions2 sponsors1 location
NCT05822037
CT0594CP CAR-T Cells in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia
NARecruiting
6 participants
Started: Apr 12, 2023 · Completed: Apr 29, 2026
2 conditions2 sponsors1 location
NCT05893693
Assess the Safety and Efficacy of CT0594CP Cells in Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia
NARecruiting
12 participants
Started: Apr 12, 2023 · Completed: Jan 1, 2026
2 conditions2 sponsors1 location
NCT04756648
Phase I Clinical Trial of CT0180 Cells in the Treatment of Hepatocellular Carcinoma
PHASE1Active, not recruiting
21 participants
Started: Mar 10, 2021 · Completed: Jun 1, 2026
1 condition2 sponsors1 location
NCT04404595
Claudin18.2 CAR-T (CT041) in Patients with Gastric, Pancreatic Cancer, or Other Specified Digestive Cancers
PHASE1/PHASE2Active, not recruiting
110 participants
Started: Oct 23, 2020 · Completed: Sep 1, 2035
2 conditions1 sponsor16 locations
NCT04581473
Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell Injection
PHASE1/PHASE2Active, not recruiting
192 participants
Started: Oct 23, 2020 · Completed: Jun 30, 2038
3 conditions3 sponsors24 locations
NCT03915184
Clinical Trial to Evaluate Zevor-cel (CT053) in Patients With Relapsed and/or Refractory Multiple Myeloma (LUMMICAR STUDY 2)
PHASE1/PHASE2Active, not recruiting
105 participants
Started: Sep 25, 2019 · Completed: Dec 31, 2034
1 condition1 sponsor13 locations
NCT03975907
Clinical Trial to Evaluate CT053 in Patients With Relapsed and/or Refractory Multiple Myeloma (LUMMICAR STUDY 1)
PHASE1/PHASE2Active, not recruiting
121 participants
Started: Jun 10, 2019 · Completed: Dec 31, 2025
1 condition14 sponsors23 locations